Hormone replacement therapy: reassessing the risks and benefits.
Although the association between postmenopausal hormone use and breast cancer has not been clarified, there is nothing indefinite about the survival advantage conferred by hormone replacement therapy. Cardiovascular and fracture-related deaths so outnumber breast cancer deaths that even women with family histories of the latter are likely to benefit from low-potency estrogen replacement.
Shoupe
D
D
University of Southern California School of Medicine, Los Angeles, USA.
D000075202:Contraindications; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D008875:Middle Aged; D009026:Mortality / Q000639:trends; D017698:Postmenopause / Q000187:drug effects; D012307:Risk Factors; D045165:Testosterone Congeners / Q000008:administration & dosage / Q000009:adverse effects
D045166:Estradiol Congeners; D045165:Testosterone Congeners